| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.095 | 0.5 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |